Adaptive Biotechnologies (ADPT)
(Delayed Data from NSDQ)
$10.91 USD
+0.58 (5.61%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $10.95 +0.04 (0.37%) 7:14 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Adaptive Biotechnologies Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADPT 10.91 +0.58(5.61%)
Will ADPT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADPT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADPT
Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
ADPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
Other News for ADPT
Adaptive Biotechnologies Corp (ADPT) Q2 2025: Everything You Need To Know Ahead Of Earnings
Adaptive Biotechnologies Q2 2025 Earnings Preview
COIN, BMNR, RBLX: Cathie Wood Buys Over $54M of Crypto Stocks, Dumps Roblox Stake
Adaptive Biotechnologies price target raised by $2 at BTIG, here's why
BTIG Increases Price Target for Adaptive Biotechnologies (ADPT) to $13